Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX2QIE
|
||||
Drug Name |
(S)-2-({5-[3-(2,4-Diamino-6-oxo-1,6-dihydro-pyrimidin-5-ylsulfanyl)-propyl]-4-methyl-thiophene-2-carbonyl}-amino)-pentanedioic acid
|
||||
Synonyms |
CHEMBL315627
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C18H23N5O6S2
|
||||
Canonical SMILES |
Cc1cc(sc1CCCSc2c(N)nc(N)nc2O)C(=O)N[C@@H](CCC(=O)O)C(=O)O
|
||||
InChI |
InChI=1S/C18H23N5O6S2/c1-8-7-11(15(26)21-9(17(28)29)4-5-12(24)25)31-10(8)3-2-6-30-13-14(19)22-18(20)23-16(13)27/h7,9H,2-6H2,1H3,(H,21,26)(H,24,25)(H,28,29)(H5,19,20,22,23,27)/t9-/m0/s1
|
||||
InChIKey |
RPXDQPDLDPKBHG-VIFPVBQESA-N
|
||||
Target and Pathway | |||||
Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
Histamine H1 receptor | Target Info | [1587926] | |||
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.